INMB vs TXN · rev $50.0K vs P/E 52, rev $10.29B
INmune Bio Inc (INMB) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
INMB currently screens at market cap $33.5M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the INMB and TXN stock pages for the full models.
Not investment advice.